Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice.
about
The elements of life and medicinesComparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.
P2860
Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Significant systemic therapeut ...... te cancer in mice.
@en
Significant systemic therapeut ...... te cancer in mice.
@nl
type
label
Significant systemic therapeut ...... te cancer in mice.
@en
Significant systemic therapeut ...... te cancer in mice.
@nl
prefLabel
Significant systemic therapeut ...... te cancer in mice.
@en
Significant systemic therapeut ...... te cancer in mice.
@nl
P2093
P356
P1476
Significant systemic therapeut ...... te cancer in mice.
@en
P2093
Henry B Spitz
Julien Torgue
Lingling Cui
Nathan Schneider
Pingping Chen
Samuel Glover
Zhongyun Dong
Zongqing Tan
P304
P356
10.3892/IJO.2012.1357
P50
P577
2012-02-06T00:00:00Z